The effect of Honda walking assist on walking in patients with Parkinson's disease Version 2

The effect of Honda walking assist on walking in patients with Parkinson's disease Version 2 - The effect of Honda walking assist on walking in patients with Parkinson's disease Version 2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028654

Enrollment

Registered

2017-08-14

Start date

2016-09-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

The direct effect study: Patients did 10 meters and 3 minutes walking wearing HWA with and without stride assist six times on separate days. We estimated the velocity and step length in 10 m walking,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Parkinson's disease Having the ability to walk independently with/without canes or a walker Having gait disorders associated with Parkinson's disease

Exclusion criteria

Exclusion criteria: Dementia No ability to to walk independently with/without canes or a walker

Design outcomes

Primary

Measure	Time frame
1. The direct effect study: Patients did 10 meters and 3 minutes walking wearing HWA with and without stride assist six times on separate days. We estimated the velocity and step length in 10 m walking, and distance and step length in 3 min walking. 2. The indirect effect study: Patients did step and walking rehabilitation for 30 min, 4 times / 4 weeks without HWA (phase A1) , using HWA (phase B1), without HWA (phase A2) and using HWA (phase B2). We evaluated the velocity and step length in 10 m walking, and distance and step length in 3 min walking, without HWA at the pre-intervention and each post-phase.	—

Measure

Time frame

1. The direct effect study: Patients did 10 meters and 3 minutes walking wearing HWA with and without stride assist six times on separate days. We estimated the velocity and step length in 10 m walking, and distance and step length in 3 min walking. 2. The indirect effect study: Patients did step and walking rehabilitation for 30 min, 4 times / 4 weeks without HWA (phase A1) , using HWA (phase B1), without HWA (phase A2) and using HWA (phase B2). We evaluated the velocity and step length in 10 m walking, and distance and step length in 3 min walking, without HWA at the pre-intervention and each post-phase.

—

Secondary

Measure	Time frame
Berg Balance Scale(BBS), UPDRS(Part3), MDS-UPDRS 3.11(freezing of gait), Freezing of gait questionnaire(FOG-Q) in the indirect effect study.	—

Countries

Japan

Contacts

Public ContactNoriko Kawashima

Kawashima Neurology Clinic Neurology

nkawashi@pf7.so-net.ne.jp0466-55-1358

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

The effect of Honda walking assist on walking in patients with Parkinson&#39;s disease Version 2